Log in  First Connection?

Thyroid Diseases: Archives News of the month

Machine learning in lymphocyte and immune biomarker analysis for childhood thyroid diseases in China

 Published on 03/04/2025 |  Original article (Abstract)  | Yang Ruizhe et al. | BMC Pediatrics 2024; 25(1): 249

Thyroid diseases (TD) are widespread, affecting approximately 5% of the general population, and they are often diagnosed in children [1, 2–3]. One example is autoimmune thyroid disease (AITD), which includes Graves’ disease (GD) and Hashimoto’s thyroiditis (HT). AITD is characterized...

The impact of thyroid function on surgical prognosis in patients undergoing cardiac and major vascular surgeries

 Published on 27/03/2025 |  Original article (Abstract)  | Sun Qi et al. | Journal of Cardiothoracic Surgery 2025; 20(1): 152

Cardiac and major vascular surgeries are among the most complex and high-risk procedures in modern medicine, often associated with significant morbidity and mortality [1, 2–3]. These surgeries require meticulous preoperative planning, intraoperative precision, and comprehensive postoperative care...

Pilot study of ultrasound-guided microwave ablation for inactivating excess remnant thyroid after surgery in patients with differentiated thyroid cancer

 Published on 20/03/2025 |  Original article (Abstract)  | Chen Yihao et al. | BMC Cancer 2025; 25(1): 469

Thyroid cancer is a prevalent endocrine malignancy globally, with a rising global incidence over recent decades and a 20% increase in age-standardized incidence, driven by enhanced early tumor screening, a greater prevalence of personal risk factors, and increased exposure to environmental risks [1,...

Advanced pathological subtype classification of thyroid cancer using efficientNetB0

 Published on 13/03/2025 |  Original article (Abstract)  | Guo Hongpeng et al. | Diagnostic Pathology 2025; 20(1): 28

Thyroid cancer is one of the most common malignancies of the endocrine system worldwide, with its incidence rising significantly over the past few decades [1, 2–3]. Although its overall prognosis is favorable, there are significant differences in clinical presentation and biological behavior among...

Two or three weeks of thyroid hormone withdrawal before initial 131I therapy for patients with differentiated thyroid carcinoma?

 Published on 06/03/2025 |  Original article (Abstract)  | Wang Yueqi et al. | BMC Cancer 2024; 25(1): 370

Differentiated thyroid cancer (DTC), including papillary thyroid cancer and follicular thyroid cancer, is the most common malignant tumor of the thyroid, accounting for more than 90% of cases [1, 2]. Although the global incidence of DTC has been increasing continuously, the mortality of DTC patients...